V. Arunan

发表

MCT1 Inhibitor AZD3965 Increases Mitochondrial Metabolism, Facilitating Combination Therapy and Noninvasive Magnetic Resonance Spectroscopy.

Paul D. Smith, M. Leach, H. Parkes, 2017, Cancer research.

MCT 1 inhibitor AZD 3965 increases mitochondrial metabolism , facilitating combination therapy and non-invasive magnetic resonance spectroscopy

Paul D. Smith, M. Leach, H. Parkes, 2017 .

Histone deacetylase inhibition increases levels of choline kinase alpha and phosphocholine facilitating non-invasive imaging in human cancers

J. Griffiths, M. Leach, P. Workman, 2011 .

Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours

M. Leach, H. Parkes, M. Valenti, 2015, British Journal of Cancer.

Size selectivity of hyaluronan molecular sieving by extracellular matrix in rabbit synovial joints

R. Mason, J. Levick, S. Sabaratnam, 2005, The Journal of physiology.

Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI

J. Waterton, M. Leach, S. Walker-Samuel, 2013, British Journal of Cancer.

MEK1/2 inhibition decreases lactate in BRAF-driven human cancer cells.

M. Leach, P. Workman, R. Marais, 2013, Cancer research.

MEK 1 / 2 inhibition decreases lactate in BRAF-driven human cancer cells

M. Leach, P. Workman, R. Marais, 2013 .

Therapeutics , Targets , and Chemical Biology MEK 1 / 2 Inhibition Decreases Lactate in BRAF-Driven Human Cancer Cells

M. Leach, P. Workman, R. Marais, 2013 .

Modulation of melanoma cell phospholipid metabolism in response to heat shock protein 90 inhibition

M. Leach, P. Workman, S. Sharp, 2010, Oncotarget.

Histone deacetylase inhibition increases levels of choline kinase α and phosphocholine facilitating noninvasive imaging in human cancers.

J. Griffiths, M. Leach, P. Workman, 2012, Cancer research.